Autopsy report · NCT00530270
Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
Cause of deathSlow enrollment
“Study was closed June 23, 2008 due to low enrollment.”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 1 year 11 months before it stopped.
- 12 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Sponsor type
- University, hospital or other
- Conditions
- Anemia, Sickle Cell
- Interventions
- Dexamethasone; Placebo
- Participants
- 12
- Sites
- 6
- Countries
- United States
Trials that died the same way
- Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine
“Study was closed due to low subject enrollment at site.” - Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
“Study closed before total enrollment met.” - A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
“Study closed to enrollment due to low accrual.” - Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
“Study closed due to slow enrollment.” - Reconstruction Flaps for Nasal Surgical Wounds RCT
“Study closed before enrollment could begin.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.